Clinical Trial Update: Safety and Efficacy of Topical Recombinant Human Thrombin(rhThrombin) for Surgical Hemostasis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating safety and efficacy of topical recombinant human thrombin for surgical hemostasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Surgical Hemostasis

Drugs mentioned

• Recombinant human thrombin (rhThrombin) (thrombin)

Snippet

Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd | Conditions: Surgical Hemostasis | Phase 3 | Status: COMPLETED